PRVA 📈 Privia Health - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74276R1023

PRVA: Technology, Tools, Services, Networks, Medical, Care

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Web URL: https://www.priviahealth.com

Additional Sources for PRVA Stock

PRVA Stock Overview

Market Cap in USD 2,624m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Services
IPO / Inception 2021-04-28

PRVA Stock Ratings

Growth 5y -29.3%
Fundamental 26.7%
Dividend -
Rel. Strength Industry -743
Analysts 4.57/5
Fair Price Momentum 18.48 USD
Fair Price DCF 21.94 USD

PRVA Dividends

No Dividends Paid

PRVA Growth Ratios

Growth Correlation 3m 73.6%
Growth Correlation 12m -18.3%
Growth Correlation 5y -71.2%
CAGR 5y -3.65%
CAGR/Mean DD 5y -0.08
Sharpe Ratio 12m -0.27
Alpha -36.25
Beta 0.76
Volatility 53.99%
Current Volume 2385.4k
Average Volume 20d 655.3k
What is the price of PRVA stocks?
As of December 22, 2024, the stock is trading at USD 20.07 with a total of 2,385,377 shares traded.
Over the past week, the price has changed by -3.68%, over one month by -4.64%, over three months by +3.55% and over the past year by -14.99%.
Is Privia Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Privia Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRVA as of December 2024 is 18.48. This means that PRVA is currently overvalued and has a potential downside of -7.92%.
Is PRVA a buy, sell or hold?
Privia Health has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy PRVA.
  • Strong Buy: 14
  • Buy: 5
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PRVA stock price target?
According to ValueRays Forecast Model, PRVA Privia Health will be worth about 20.4 in December 2025. The stock is currently trading at 20.07. This means that the stock has a potential upside of +1.59%.
Issuer Forecast Upside
Wallstreet Target Price 26.2 30.5%
Analysts Target Price 37.1 84.8%
ValueRay Target Price 20.4 1.6%